{
 "id": 1,
 "name": "Updated CustomReportTest1",
 "type": "NGS",
 "methodology": "Updated Methodology",
 "limitations": "Updated Limitations",
 "references": "Updated References",
 "custom_report_genes": [
  {
   "id": 1,
   "name": "Updated CustomReportGene1",
   "summary": "Updated Summary1",
   "transcript": "Updated  Transcript1",
   "custom_report_variations": [
    {
     "id": 1,
     "variation": "Updated CustomReportVariation1",
     "description": "Description3",
     "classification": "VARIANT_UNCERTAIN_SIGNIFICANCE",
     "zygosity": "HOMOZYGOUS_ALTERNATE"
    },
    {
     "id": 4,
     "variation": "New CustomReportVariation2",
     "description": "Description2",
     "classification": "LIKELY_PATHOGENIC",
     "zygosity": "HOMOZYGOUS_ALTERNATE"
    }
   ]
  },
  {
   "id": 5,
   "name": "New CustomReportGene2",
   "summary": "",
   "transcript": "",
   "custom_report_variations": []
  }
 ],
 "custom_report_result": {
  "id": 1,
  "result": "One Pathogenic variant identified in RAD50. RAD50 is associated with autosomal dominant hereditary breast cancer and autosomal recessive Nijmegen breakage syndrome-like disorder. Additional Variant(s) of Uncertain Significance identified.",
  "finding": "POSITIVE"
 },
 "custom_report_interpretation": {
  "id": 1,
  "interpretation": "This result is consistent with a predisposition to, or diagnosis of, autosomal dominant RAD50-related conditions."
 }
}